Colorectal cancer (CRC) persists as one of the most prevalent and deadly tumor types in
both men and women worldwide. This is in spite of widespread, effective measures of …

According to a report by the National Cancer Institute, colorectal cancer (CRC) is one of the
most common types of cancer worldwide. CRC is often recognized too late for successful …

G protein-coupled receptors (GPCRs) regulate an array of fundamental biological
processes, such as growth, metabolism and homeostasis. Specifically, GPCRs are involved …

Introduction: Despite remarkable advances in tumor treatment, many patients still die from
common tumors (breast, prostate, lung, CNS, colon, and pancreas), and thus, new …

Targeted delivery of chemotherapeutics and diagnostic agents conjugated to carrier ligands
has made significant progress in recent years, both in regards to the structural design of the …

Glutamine metabolism is essential for tumorigenesis of colorectal cancer, cancer cells
remodel their glutamine metabolic pathways to fuel rapid proliferation. SLC1A5 is an …

Colon cancer is the third most common malignancy and one of the leading causes of cancer‐
associated mortality worldwide. Neuronal pentraxin 1 (NPTX1) is associated with tumor …

Cutaneous toxicities associated with EGFR inhibitors (EGFRIs) have a significant impact on
patient treatment continuation, quality of life and healthcare resource utilization. This paper …

Colorectal cancer (CRC) is a major health burden worldwide, and thus, optimised diagnosis
and treatments are imperative. E2F transcription factors (E2Fs) are a family of transcription …

Colorectal cancer (CRC) is the third most common cause of cancer related death worldwide.
Furthermore, with more than 1.2 million cases registered per year, it constitutes the third …